Lauren L. Ott

Also affiliated with Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic in Florida, Massachusetts Institute of Technology

MedicineBiochemistry, Genetics and Molecular BiologyPhysics and AstronomyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits”.

DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0003

N/A

0.467DataRank · unranked

12 citations

Emily J. Smith, Michael S. Regan, Sylwia A. Stopka, Gerard Baquer, Zhiyi Xue +19 more

The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts

Neuro-Oncology(2025)10.1093/neuonc/noaf102

N/A

0.312DataRank · unranked

7 citations

Ann C. Mladek, Sneha Rathi, Sonia Jain, Rachael A. Vaubel, Lateef A Odukoya +17 more

Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0664

N/A

0.241DataRank · unranked

4 citations

Sneha Rathi, Margaret A. Connors, Michael P. Grams, Rachael A. Vaubel, Katrina K. Bakken +13 more

Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0244

N/A

0.165DataRank · unranked

2 citations

Wenjuan Zhang, Ju-Hee Oh, Ann C. Mladek, Tugce I. Pasa, Jennifer Gantchev +24 more

PK-PD-efficacy modeling of brigimadlin in MDM2-amplified glioblastoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2071

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Danielle M. Burgenske, Katie L. Waller, Paul A. Decker, Matt Kosel +13 more

The impact of therapeutic radiation on drug distribution across the blood-brain barrier in normal mouse brain and orthotopic glioblastoma tumors

Neuro-Oncology(2025)10.1093/neuonc/noaf093

N/A

0DataRank · unranked

4 citations

Michael P. Grams, Rajneet K. Oberoi, Ju‐Hee Oh, Paul A. Decker, Terence T. Sio +12 more

Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf259

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Nishika Karbhari, Ju-Hee Oh, Katie L. Waller, Ann C. Mladek +16 more